Wiener klinische Wochenschrift

, Volume 118, Issue 13–14, pp 382–388 | Cite as

Cardiogenic shock – an inflammatory disease

  • Gottfried Heinz
Perspective

Keywords

Cardiogenic shock L-NAME L-NMMA LINCS TRIUMPH Pexelizumab COMMA 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330: 1724–1730PubMedCrossRefGoogle Scholar
  2. Creamer JE, Edwards JD, Nightingale P (1990) Hemodynamic and oxygen transport variables in cardiogenic shock secondary to acute myocardial infarction, and response to treatment. Am J Cardiol 65: 1297–1300PubMedCrossRefGoogle Scholar
  3. Muir AL, Kirby BJ, King AJ, Miller HC (1970) Mixed venous oxygen saturation in relation to cardiac output in myocardial infarction. Br Med J 31 (4): 276–278CrossRefGoogle Scholar
  4. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341: 625–634PubMedCrossRefGoogle Scholar
  5. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T (2000) Cardiogenic shock complicating acute myocardial infarction – etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol 36 [3 Suppl A]: 1063–1070PubMedCrossRefGoogle Scholar
  6. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM (1999) Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340: 1162–1168PubMedCrossRefGoogle Scholar
  7. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators (2005) Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294: 448–454PubMedCrossRefGoogle Scholar
  8. Hasdai D, Holmes DR Jr, Califf RM, Thompson TD, Hochman JS, Pfisterer M, Topol EJ (1999) Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. Am Heart J 138: 21–31PubMedCrossRefGoogle Scholar
  9. Buchwald AB, Meyer T, Scholz K, Schorn B, Unterberg C (2001) Efficacy of balloon valvuloplasty in patients with critical aortic stenosis and cardiogenic shock – the role of shock duration. Clin Cardiol 24: 214PubMedCrossRefGoogle Scholar
  10. Brodie BR, Stuckey TD, Muncy DB, Hansen CJ, Wall TC, Pulsipher M, Gupta N (2003) Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 145 (4): 708–715PubMedCrossRefGoogle Scholar
  11. Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ (2002) Ventricular septal rupture after acute myocardial infarction. N Engl J Med 347: 1426–1432PubMedCrossRefGoogle Scholar
  12. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110: 588–636PubMedCrossRefGoogle Scholar
  13. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE 3rd, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A Jr, Gregoratos G, Ryan TJ, Smith SC Jr (1999) 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 34 (3): 890–911PubMedCrossRefGoogle Scholar
  14. Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, Jiang X, Slater J, LeJemtel T, Hochman JS; SHOCK Investigators (2003) Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24: 828–837PubMedCrossRefGoogle Scholar
  15. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Dovellini EV, Bolognese L, Santoro GM (2002) Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 90: 353–357PubMedCrossRefGoogle Scholar
  16. Zeymer U, Tebbe U, Weber M, Vohringer HF, Jaksch R, Bischoff KO, Toepel W, Marsalek P, Horn S, Neuhaus KL; ALKK Study Group (2003) Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial. J Invasive Cardiol 15: 385–389PubMedGoogle Scholar
  17. Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G (2003) Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaestesiol Scand 47: 1251–1256CrossRefGoogle Scholar
  18. Delle Karth G, Heinz G (2004) Levosimendan in cardiology and intensive care medicine. Wien Klin Wochenschr 116 (1–2): 6–14PubMedCrossRefGoogle Scholar
  19. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD (1999) Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 72: 3–10PubMedCrossRefGoogle Scholar
  20. Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G (2002) Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 30: 1987–1994PubMedCrossRefGoogle Scholar
  21. Remskar M, Horvat M, Hojker S, Noc M (2002) Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114 (5–6): 205–210PubMedGoogle Scholar
  22. Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS for the SHOCK investigators (2005) Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Ann Int Med 165: 1643–1650CrossRefGoogle Scholar
  23. Hochman JS (2003) Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107: 2998–3002PubMedCrossRefGoogle Scholar
  24. Cotter G, Kaluski E, Blatt A, Milovanov O, Moshkovitz Y, Zaidenstein, Salah A, Alon D, Michovitz Y, Metzger M, Vered Z, Golik A (2000) L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock. Circulation 101: 1358–1361PubMedGoogle Scholar
  25. Cotter G, Kaluski E, Milo O, Blatt A, Salah A, Hendler A, Krakover R, Golick A, Vered Z (2003) LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J 24: 1287–1295PubMedCrossRefGoogle Scholar
  26. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early Goal-Directed Therapy Collaborative Group: Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368PubMedCrossRefGoogle Scholar
  27. Pölönen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J (2000) A prospective, randomized study of goaloriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 90: 1052–1059PubMedGoogle Scholar
  28. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED (2005) Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial. Crit Care 9 (6): R687–R693PubMedCrossRefGoogle Scholar
  29. Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS (2000) Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 108: 374PubMedCrossRefGoogle Scholar
  30. Lorente JA, Landin L, Canas P, Delgado MA, Albaya A, Renes E, Jorge P, Liste D (1996) Effects of nitric oxide synthase inhibition on the cardiovascular response to low output shock. Crit Care Med 24: 482–487PubMedCrossRefGoogle Scholar
  31. Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochmann JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PS for the COMMA investigators (2003) The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 108: 1184–1190PubMedCrossRefGoogle Scholar
  32. Lim N, Dubois MJ, DeBacker D, Vincent JL (2003) Do all nonsurvivors of cardiogenic shock die with a low cardiac index? Chest 124: 1885–1891PubMedCrossRefGoogle Scholar
  33. Rivers EP, Ander SD, Powell D (2001) Central venous oxyten saturation monitoring in the critically ill patient. Curr Opin Crit Care 7: 204–211PubMedCrossRefGoogle Scholar
  34. Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B (1996) Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 109 (5): 1302–1312PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Gottfried Heinz

There are no affiliations available

Personalised recommendations